Login

Maxime Séché is the Chief Executive Officer of Séché Environnement, a leading environmental services company. 00:10:00

Share On Facebook Share On Twitter

Joël Séché, Président Fondateur de Séché Environnement.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Building a Growth Machine|Brian Balfour,Venture Partner,Long Journey Ventures
00:10:00
Roth IRA vs. Traditional IRA: Which Should You Choose? | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
Australian Mining and the Green Metals Super Cycle
00:10:00
"Pioneering Quantitative Investing: John Chisholm on Machine Learning, ESG, and Value Investing"
00:10:00
Shoper President Marcin Kuśmierz Explores Results, Shoplo Integration, and Future Plans | Marcin Kuśmierz, President , Shoper SA.
00:10:00
4GLOBAL focused on transition after "very good" 2022 | Eloy Mazon, CEO, 4Global PLC4GBL:LSE
00:10:00
Fernando González Olivieri Addresses December 2023 Graduates at Tecnológico de Monterrey | Fernando Angel Angel Gonzalez Olivieri - CEO of Cemex
00:00:00
CEO Michiel Langezaal is excited about his EV-inspired moment. | MICHIEL LANGEZAAL, CEO AT FASTNED BV
00:10:00
Action SA reveals 18-member 'cabinet in waiting' | André Coetzee, CEO, Action SAACT:WSE
00:10:00
Advancing Neoantigen-Targeted Therapies with Jenosha's Atlas Platform
00:00:00
Development of a mobile system for managing type 1 diabetes - Eric Beard, Chairman and CEO of Cellnovo Group
00:10:00
The Importance of Relationships in Venture Fundraising|Jim Andelman,Co-Founder and Managing Partner,Bonfire Ventures

© 2026 Nehu